Granulocyte colony-stimulating factor following peripheral-blood progenitor-cell transplant in non-Hodgkin's lymphoma.

199549 citationsJournal Article

Authors

Sergio Cortelazzo · Azienda Ospedaliero Universitaria Ospedali Riuniti

Piera Viero

Abstract

Provided an optimal dose of circulating progenitors is infused, NHL patients transplanted with PBPC do not benefit by the administration of hematopoietic growth factors.

Topics & Keywords

Neutropenia and Cancer Infections Hematopoietic Stem Cell Transplantation Blood disorders and treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 13, Issue 4, pp. 935-941

DOI: 10.1200/jco.1995.13.4.935

Field-Weighted Citation Impact: 3.42